22 May 2025

Other valvular and structural interventions TAVI

Innovations in transcatheter aortic valve devices and techniques

Spokesperson: S. Baldus

Anchorperson: A. Baumbach

Summary

Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft prospective studies. Additionally, discover novel approaches such as the double-balloon aortic valvuloplasty via bilateral radial access and one-year follow-up results from the TaurusTrio heart valve in severe aortic regurgitation cases.

Speaker

F. L. Ribichini

A new self-expandable trans-catheter aortic valve. Initial clinical experience in small annuli

Download presentation

Speaker

M. Aetesam-Ur-Rahman

Safety and performance of Hydra self-expanding THV: Six months outcomes from the GENESIS-II study

Download presentation

Speaker

H. Eltchaninoff

Up to 12-month safety and performance results of the 100 patients treated over the Valvosoft prospective, multi-centre, single-arm first-in-human and pivotal studies

Download presentation

Speaker

G. Song

From align aortic regurgitation to alter aortic regurgitation: one-year follow-up of TaurusTrio heart valve for severe aortic regurgitation

Download presentation